Neuroone Medical Technologies (NMTC) Assets Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.48% |
| Dec 31, 2025 | 32.08% |
| Sep 30, 2025 | 100.85% |
| Jun 30, 2025 | 120.24% |
| Mar 31, 2025 | -17.39% |
| Dec 31, 2024 | 11.54% |
| Sep 30, 2024 | -33.68% |
| Jun 30, 2024 | -14.68% |
| Mar 31, 2024 | -25.12% |
| Dec 31, 2023 | -39.73% |
| Sep 30, 2023 | -36.85% |
| Jun 30, 2023 | -50.24% |
| Mar 31, 2023 | -48.86% |
| Dec 31, 2022 | -43.78% |
| Sep 30, 2022 | 61.52% |
| Jun 30, 2022 | 17.96% |
| Mar 31, 2022 | 18.22% |
| Dec 31, 2021 | 117.15% |
| Sep 30, 2021 | 66.78% |
| Jun 30, 2021 | 119.81% |
| Mar 31, 2021 | 757.82% |
| Dec 31, 2020 | 197.61% |
| Sep 30, 2020 | 793.66% |
| Jun 30, 2020 | 190.51% |
| Mar 31, 2020 | -46.05% |
| Dec 31, 2019 | 360.38% |
| Sep 30, 2019 | 143.52% |
| Jun 30, 2019 | 568.75% |
| Mar 31, 2019 | 956.27% |
| Dec 31, 2018 | 131.03% |
| Sep 30, 2018 | -18.33% |
| Dec 31, 2017 | -66.97% |
| Sep 30, 2017 | 6,161.68% |
| Dec 31, 2016 | 41,082.26% |
| Dec 31, 2015 | 796.59% |
| Dec 31, 2014 | -60.95% |
| Jun 30, 2014 | -49.18% |
| Mar 31, 2014 | -90.26% |
| Dec 31, 2013 | -53.04% |
| Sep 30, 2013 | -59.06% |
| Jun 30, 2013 | -77.87% |
| Mar 31, 2013 | -38.39% |
| Dec 31, 2012 | -91.93% |
| Sep 30, 2012 | -69.75% |
| Jun 30, 2012 | 2,021.40% |
| Dec 31, 2011 | 51.73% |